First, we work with you to define the objectives of the State of the Art Evaluation and agree on a timeframe so that the evaluation is completed in time for any deadlines. The State of the Art Evaluation is performed in close connection with the target activities (clinical evaluation, clinical trial, risk management).
We identify clinical and generated non-clinical data on similar products and medical alternatives and fully document our database searches. Safety databases are also included in the search upon request, should they not already be covered by your PMS system.
The collected data is evaluated with regard to selected safety and performance parameters. For this purpose, data from similar medical devices and existing alternative treatment or diagnostic options are scrutinized.
Based on the analyzed data, parameters for the evaluation of your medical device should be worked out. If the data are solid, these can be quantitative and serve as a benchmark for your product. For clinical trials, the parameters help to determine which endpoints should be investigated. For risk management, risk acceptance limits can be set based on the data.
The State of the Art Evaluation may serve as input to your clinical evaluation plan (CEP), risk management plan, or study design rationale for your clinical trial, depending on your processes.
The state of the art is dynamic and constantly evolving. Therefore, continuous monitoring of the relevant data is necessary to provide regular up-to-date input for your processes.